Dianthus Therapeutics 320% Year: What Investors Should Know as Stakes Shift
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Why Zero Based Budgeting Is Popular explains its straightforward approach and strong results for disciplined spenders.
22,446 articlesDianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
From top holdings to regulatory risks, this guide breaks down ZKH's Q1 2026 earnings call and translates the numbers ...
As SpaceX eyes a historic IPO, the idea of jamie dimon giving spacex turning the pitch gains traction. Here’s what th...
Amazon’s biggest growth lever may not be its storefront. This article explains how AWS and AI spending could fuel a ...
When Alphabet joins the Dow Jones Industrial Average, it signals a shift in how blue-chip names are chosen and weight...
Astera Labs stock skyrocketed last month as multiple catalysts converged. This deep-dive breaks down the driving forc...
General Motors has boosted its 2026 profit outlook for the second time this year. This article breaks down which part...
A weekend surge of about 15% turned heads in the crypto world. Here’s a clear, practical breakdown of why meme token ...
Looking for breakout growth stocks hold that can power a decade of gains? This guide highlights three durable picks—N...
When a gold stock soars 200%, even savvy investors reconsider risk. This article breaks down why trimming a large pos...
For the next 10 years, dividend stocks hold next potential with steady income and growth. Discover four dependable na...
The Baupost founder made a bold, selective move: trim a large Alphabet stake and pivot to a fintech name that slumped...